(Q43257519)

17 November 2017

title

Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease (English)

1 reference

17 November 2017

0 references

H Pijl

2

0 references

author name string

N A Aziz

1

1 reference

17 November 2017

M Frölich

3

1 reference

17 November 2017

J P Schröder-van der Elst

4

1 reference

17 November 2017

C van der Bent

5

1 reference

17 November 2017

F Roelfsema

6

1 reference

17 November 2017

R A C Roos

7

1 reference

17 November 2017

publication date

21 October 2009

1 reference

European Journal of Neurology

17 November 2017

published in

1 reference

17 November 2017

volume

17

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

280-288

1 reference

Weight loss in Huntington disease increases with higher CAG repeat number

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

An anthropometric assessment of Huntington's disease patients and families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Assessment of the nutrition status of patients with Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Increased metabolism in the R6/2 mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Hypothalamic-endocrine aspects in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Altered Growth Hormone and Prolactin Responses to Dopaminergic Stimulation in Huntington's Chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Exaggerated Growth Hormone Response to Arginine Infusion in Huntington's Disease1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Abnormal Glucose Tolerance and Arginine Tolerance Tests in Huntington’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Studies of hypothalamic function in Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Motivations and methods for analyzing pulsatile hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Gastrointestinal regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Direct stimulation of ghrelin secretion by sympathetic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

AutoDecon, a deconvolution algorithm for identification and characterization of luteinizing hormone secretory bursts: description and validation using synthetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Deconvolution analysis of hormone data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Quantification of evolution from order to randomness in practical time series analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Neuroendocrine disturbances in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Ghrelin: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Ghrelin: a hormone regulating food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Somatostatin: the neuroendocrine story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Orexin loss in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Peripheral ghrelin interacts with orexin neurons in glucostatic signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Orexin A suppresses in vivo GH secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

Unified Huntington's disease rating scale: Reliability and consistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2009.02798.X

10.1111/J.1468-1331.2009.02798.X

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference